Stock KRSNAA KRSNAA DIAGNOSTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Krsnaa Diagnostics Limited Bombay S.E.

Equities

KRSNAA

INE08LI01020

Market Closed - Bombay S.E.
Other stock markets
 03:30:52 16/07/2024 pm IST 		5-day change 1st Jan Change
670.4 INR +1.32% Intraday chart for Krsnaa Diagnostics Limited -0.53% -4.95%
05/07 Krsnaa Diagnostics Bags Radiology Tele Reporting Services Contract from Indian Nuclear Facility MT
04/07 Krsnaa Diagnostics Limited Receives Tender for Providing Tele Reporting Services for Radiology At the BARC Hospital, Mumbai CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Analyst opinion has improved significantly over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • With an expected P/E ratio at 39.81 and 25.09 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last few months, analysts have been revising downwards their earnings forecast.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
KRSNAA DIAGNOSTICS LIMITED Stock Krsnaa Diagnostics Limited
-4.95% 26Cr -
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-18.17% 854.72Cr
B+
RADNET, INC. Stock RadNet, Inc.
+87.40% 463.15Cr
C+
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+16.31% 298.41Cr
B-
SYNLAB AG Stock SYNLAB AG
-3.15% 265.3Cr -
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-2.10% 189.4Cr
C-
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-53.27% 181.31Cr
B-
FLEURY S.A. Stock Fleury S.A.
-12.97% 156.12Cr
A-
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+21.59% 127.13Cr
B+
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-47.96% 106.99Cr
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. KRSNAA Stock
  4. KRSNAA Stock
  5. Ratings Krsnaa Diagnostics Limited